On July 14, 2025, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (PFS) proposed rule for Calendar Year (CY) 2026, which includes changes related to ...

2024 ASCO – American Cancer Society Cancer Prevention Award Smita Bhatia, MD, FASCO, MPH ...

Meeting 2024 ASCO Annual Meeting Session Type Oral Abstract Session Session Title Care Delivery/Models of Care Track Care Delivery and Quality Care ...

Phase 3 randomized study for evaluation of physician choice Rx versus best supportive care as second-line or beyond therapy in head and neck cancer with poor performance status.

Using Molecular Diagnostics Across the Cancer Care Continuum to Enhance the Care of Esophageal and Gastric Cancer ...

Meeting 2024 ASCO Annual Meeting Session Type Education Session Session Title Navigating High-Risk and Ultra-High-Risk Multiple Myeloma: Challenges and Emerging Strategies Track Hematologic ...

Videos and Slides Details Meeting 2017 ASCO Annual Meeting Session Type Education Session Session Title Pancreatic Adenocarcinoma: Improving Prevention and Survivorship Track Gastrointestinal ...

Meeting 2022 ASCO Annual Meeting Session Type Education Session Session Title The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor Track Sarcoma ...

Meeting 2025 ASCO Annual Meeting Session Type Education Session Session Title Advancing Perioperative Treatment Options for Localized Muscle-Invasive Bladder Cancer: A Step Forward Track Genitourinary ...

Meeting 2018 ASCO Annual Meeting Session Type Oral Abstract Session Session Title Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia Track Hematologic Malignancies—Lymphoma and Chronic ...

Meeting 2024 ASCO Annual Meeting Session Type Oral Abstract Session Session Title Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology Track Developmental Therapeutics—Molecularly ...

Meeting 2025 ASCO Annual Meeting Session Type Education Session Session Title Capturing Unicorns: No Target Is Out of the Realm of Possibility Track Developmental Therapeutics—Molecularly Targeted ...